Hariri Robert J insider trades
Hariri Robert J has filed 34 Form 4s with the SEC that we hold, for Cryoport, Inc. (CYRX) (Director), Celularity Inc (CELU) (Chief Executive Officer, Director) and Biovie INC. (BIVI) (Director). Across all of them we count 6 purchases worth $3.2M and 11 sales worth $541.1K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 9,064,539 shares of Celularity Inc worth $1.5M, dated 2023-09-29. The first filing on our record is dated 2021-07-20 and the latest 2026-06-08.
Cryoport, Inc. (CYRX)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-08-11 | S, sale reported on Form 4 | 2,000 | $86.6K | 2022-08-16 | SEC |
| 2023-09-06 | S, sale reported on Form 4 | 1,500 | $20.4K | 2023-09-12 | SEC |
| 2023-12-11 | S, sale reported on Form 4 | 1,000 | $15.5K | 2023-12-13 | SEC |
| 2023-12-14 | S, sale reported on Form 4 | 800 | $13.5K | 2023-12-18 | SEC |
| 2024-08-14 | S, sale reported on Form 4 | 1,000 | $8.4K | 2024-08-20 | SEC |
| 2024-08-16 | S, sale reported on Form 4 | 1,000 | $9.0K | 2024-08-20 | SEC |
| 2024-08-19 | S, sale reported on Form 4 | 1,000 | $9.5K | 2024-08-26 | SEC |
| 2024-11-21 | S, sale reported on Form 4 | 2,500 | $16.2K | 2024-12-02 | SEC |
| 2025-05-28 | S, sale reported on Form 4 | 12,500 | $76.2K | 2025-05-30 | SEC |
| 2025-08-22 | S, sale reported on Form 4 | 5,000 | $43.0K | 2025-08-29 | SEC |
| 2025-09-11 | S, sale reported on Form 4 | 25,000 | $242.8K | 2025-09-12 | SEC |
Celularity Inc (CELU)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-11-28 | P, purchase reported on Form 4 | 40,000 | $69.6K | 2022-11-28 | SEC |
| 2022-11-29 | P, purchase reported on Form 4 | 40,000 | $68.4K | 2022-11-29 | SEC |
| 2022-11-30 | P, purchase reported on Form 4 | 10,000 | $17.2K | 2022-11-30 | SEC |
| 2023-09-29 | P, purchase reported on Form 4 | 9,064,539 | $1.5M | 2023-10-10 | SEC |
| 2023-10-05 | P, purchase reported on Form 4 | 3,050,427 | $488.1K | 2023-10-10 | SEC |
| 2023-10-05 | P, purchase reported on Form 4 | 6,307,158 | $1.0M | 2023-10-10 | SEC |
Biovie INC. (BIVI)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1398815) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
